Prenatal Diagnosis and Management
At a Glance
Congenital chylothorax is diagnosed via prenatal ultrasound when fluid builds up around a baby's lungs. Management depends on severity and may include close monitoring, a specialized maternal diet, or fetal interventions like a thoracoamniotic shunt to drain the fluid and support lung growth.
Receiving a prenatal diagnosis of congenital chylothorax—fluid accumulation around your baby’s lungs—is a heavy burden to carry. It often turns what should be a joyful time into a period of intense medical monitoring and difficult decisions. It is completely normal to feel a mix of fear, grief, and a desperate desire for clarity.
How the Diagnosis is Made
Before birth, this condition is identified through a prenatal ultrasound. Doctors look for a pleural effusion, which appears as a dark rim of fluid surrounding one or both of the baby’s lungs [1][2].
During these scans, the medical team monitors for:
- Mediastinal Shift: If the fluid buildup is large enough, it can push the baby’s heart and other structures to one side of the chest [3].
- Polyhydramnios: An excess of amniotic fluid, which can happen if the baby has trouble swallowing because the chest fluid is pressing on the esophagus [4].
- Lung Size: Doctors check if the lungs are being compressed, which can affect how they develop [1].
Understanding Hydrops Fetalis
One of the most critical terms you may hear is hydrops fetalis. This is not a disease itself, but a sign that the baby’s body is struggling to manage fluid. It is defined as excessive fluid accumulation in at least two different areas of the baby’s body [5][6].
Common areas for fluid to build up include:
- The space around the lungs (pleural effusion)
- The space around the heart (pericardial effusion)
- The abdomen (ascites)
- Under the skin (skin edema) [7]
Hydrops is considered a “marker for poor prognosis” because it suggests the baby’s heart or lymphatic system is under significant stress [1][4]. When hydrops is present, doctors often move more quickly toward interventions to relieve the pressure [3].
Prenatal Interventions: Thoracoamniotic Shunting (TAS)
If the fluid buildup is severe or hydrops begins to develop, your team may recommend a thoracoamniotic shunt (TAS). This is a fetal procedure where a small, hollow tube (catheter) is placed through the mother’s abdomen and into the baby’s chest [3][8].
The Goal of the Shunt
The purpose of the shunt is to act as a “drain” that moves fluid from the baby’s chest into the amniotic sac [9]. By removing this fluid, the procedure aims to:
- Allow the baby’s lungs to expand and grow [3].
- Decrease pressure on the heart, which can reverse or prevent hydrops [10].
- Improve the baby’s chances of survival after birth, with some studies showing survival rates of 59% to 72% for severe cases after shunting [10][9].
- Note: While statistics can be terrifying, it is vital to know that the lower survival rates in these studies are often linked to extreme prematurity or severe underlying genetic anomalies, not just the fluid buildup itself [10].
Risks and Complications
While life-saving, TAS is a delicate procedure with risks that your team will discuss in detail:
- Catheter Displacement: The most common technical complication is the shunt moving or falling out of place as the baby moves [11][12].
- Preterm Labor: The procedure can sometimes lead to PPROM (premature rupture of the “water”) or early labor [11][13].
- Fetal Stress: Rarely, the procedure can cause a temporary drop in the baby’s heart rate [14].
Conservative Management: Maternal Diet
In some specific cases, doctors may discuss a “conservative” approach using a maternal diet modification. This involves the mother eating a diet very high in medium-chain triglycerides (MCT) and restricted in long-chain fatty acids (LCFA) [15].
The theory is that these specific fats are absorbed differently and might reduce the “flow” of chyle fluid in the baby. While this has been successful in some case reports, it is not a standard treatment for all types of fetal fluid and must be done under strict medical and nutritional supervision [15].
You are your baby’s best advocate. While you wait and monitor, focus on the facts of your specific case and the expertise of your Maternal-Fetal Medicine (MFM) team.
Common questions in this guide
How is congenital chylothorax diagnosed before birth?
What is hydrops fetalis?
What does a thoracoamniotic shunt (TAS) do?
What are the risks of a fetal shunt procedure?
Can changing my diet help treat my baby's chylothorax?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Is the fluid buildup unilateral or bilateral, and is the heart being pushed from its normal position (mediastinal shift)?
- 2.Does my baby currently meet the criteria for hydrops fetalis? How many fluid compartments are involved?
- 3.What are our hospital's specific success and complication rates for thoracoamniotic shunting (TAS)?
- 4.If we proceed with a shunt, what is the plan for monitoring for catheter displacement or migration?
- 5.Would a maternal MCT-rich, low-LCFA diet be appropriate for my specific case, or is that reserved for certain types of effusions?
- 6.How will this diagnosis change our delivery plan? Will we need to be at a Level IV NICU with fetal surgery capabilities?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (15)
- 1
Clinical features and outcomes of congenital chylothorax: a single tertiary medical center experience in China.
Wang B, Feng Y, Guo Y, et al.
Journal of cardiothoracic surgery 2022; (17(1)):276 doi:10.1186/s13019-022-02009-z.
PMID: 36303149 - 2
Congenital chylothorax: Current evidence-based prenatal and post-natal diagnosis and management.
De Angelis LC, Bellini T, Witte MH, et al.
Lymphology 2019; (52(3)):108-125.
PMID: 31874123 - 3
[Outcomes of severe primary fetal hydrothorax treated by prenatal intervention].
Xia B, Yu G, Hong C, et al.
Zhonghua fu chan ke za zhi 2018; (53(8)):522-527 doi:10.3760/cma.j.issn.0529-567x.2018.08.003.
PMID: 30138961 - 4
Clinical Course and Outcome of Non-Immune Fetal Hydrops in Singleton Pregnancies.
Reischer T, Muth B, Catic A, et al.
Journal of clinical medicine 2022; (11(3)) doi:10.3390/jcm11030702.
PMID: 35160154 - 5
Nonimmune Hydrops Fetalis - More Than Meets the Eye?
Kilby MD
The New England journal of medicine 2020; (383(18)):1785-1786 doi:10.1056/NEJMe2029914.
PMID: 33027567 - 6
Association between mucopolysaccharidosis Type VII and hydrops fetalis.
Holtz M, Montaño AM, Sly WS
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2020; (55(3)):416-417 doi:10.1002/uog.20371.
PMID: 31180609 - 7
Case Report of Meconium Peritonitis: A Rare Cause of Non-immune Hydrops Fetalis.
Maddali R, Alvarez-Gell C, Balasundaram P, Sakr M
Cureus 2024; (16(11)):e72860 doi:10.7759/cureus.72860.
PMID: 39624559 - 8
Fetal Thoracoamniotic Shunting in a Case of Congenital Pulmonary Airway Malformations with Hydrops Fetalis.
Nitta H, Taira Y, Kinjo T, et al.
AJP reports 2017; (7(3)):e185-e187 doi:10.1055/s-0037-1606830.
PMID: 28948063 - 9
Long-Term Outcomes After Thoracoamniotic Shunt for Pleural Effusions With Secondary Hydrops.
Chon AH, Chmait HR, Korst LM, et al.
The Journal of surgical research 2019; (233()):304-309 doi:10.1016/j.jss.2018.08.022.
PMID: 30502263 - 10
Prenatal factors associated with neonatal survival of infants with congenital chylothorax.
Dorsi M, Giuseppi A, Lesage F, et al.
Journal of perinatology : official journal of the California Perinatal Association 2018; (38(1)):31-34 doi:10.1038/jp.2017.150.
PMID: 29048403 - 11
OK-432 Treatment of Early Fetal Chylothorax: Pregnancy Outcome and Long-Term Follow-Up of 14 Cases.
Nørgaard LN, Nygaard U, Damm JA, et al.
Fetal diagnosis and therapy 2019; (46(2)):81-87 doi:10.1159/000489775.
PMID: 30282075 - 12
Refractory tension pneumothorax as a result of an internally displaced thoracoamniotic shunt in an infant with a congenital pulmonary airway malformation.
Law BH, Bratu I, Jain V, Landry MA
BMJ case reports 2016; (2016()).
PMID: 27469386 - 13
Fetal Distress and Neonatal Death After Thoracoamniotic Shunting Therapy Due to Hydrops Associated With Transient Abnormal Myelopoiesis.
Muraoka J, Yoshimoto N, Ohsawa A, et al.
Cureus 2022; (14(9)):e28991 doi:10.7759/cureus.28991.
PMID: 36225415 - 14
Pseudoamniotic Band Syndrome Post Fetal Thoracoamniotic Shunting for Bilateral Hydrothorax.
Han M, Afshar Y, Chon AH, et al.
Fetal and pediatric pathology 2017; (36(4)):311-318 doi:10.1080/15513815.2017.1313915.
PMID: 28453379 - 15
Maternal MCT Oil-Based Diet in the Treatment of Primary Fetal Pleural Effusion: Case Reports.
Roozmeh S, Shakiba AM, Vafaei H, et al.
Clinical case reports 2025; (13(11)):e70918 doi:10.1002/ccr3.70918.
PMID: 41179616
This page provides educational information about the prenatal diagnosis and management of congenital chylothorax. It is not medical advice; always consult your Maternal-Fetal Medicine (MFM) team for your specific pregnancy care plan.
Get notified when new evidence is published on Congenital chylothorax.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.